1. Brolucizumab: First Approval
2. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
3. Beovu update for ASRS members. American society of retina specialists; 2020. Available from: https://www.asrs.org/clinical/clinical-updates/960/Beovu-Update-for-ASRS-Members. Accessed August 31, 2023.
4. Witkin AJ, Hahn P, Murray TG. Occlusive retinal vasculitis following intravitreal brolucizumab: an ASRS research and safety in therapeutics (ReST) committee report. Retina Times; 2020. Available from: https://www.asrs.org/publications/retina-times/details/2929/oclusive-retinal-vasculitis-following-intravitreal-brolucizumab-an-asrs-research-and-safety-in-thera. Accessed August 31, 2023.